Announcements Trials
Browse Landscape

Phase

Phase 2 109Phase 1 19Phase 3 15Phase 1/2 14Phase NA 12Phase 2/3 3Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Plasma cell 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 2Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Lymphoid 1Hematologic Neoplasms 1

Interventions

nilotinib 12Imatinib Mesylate 11Dasatinib 3ruxolitinib 2posaconazole 2fludarabine 2bosutinib 2asciminib 2Cyclophosphamide 2Busulfan 2zanubrutinib 1trametinib 1pegaspargase 1flumatinib 1fludarabine phosphate 1eltrombopag 1dabrafenib 1avapritinib 1Thiotepa 1Rituximab 1Radiotherapy 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Micafungin 1Interferons 1Idarubicin 1Hydroxyurea 1Growth Hormone 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Busulfan × Myeloid × Clear all
NCT00361140 2017-03-03

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

H. Lee Moffitt Cancer Center and Research Institute

Phase 4 Completed
72 enrolled 10 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01339988 2011-04-21

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
10 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡